492P Single-molecule longitudinal cfDNA profiling reveals epigenetic modifications at progression on CDK4/6 inhibitors in advanced breast cancer.

Saved in:
Bibliographic Details
Title: 492P Single-molecule longitudinal cfDNA profiling reveals epigenetic modifications at progression on CDK4/6 inhibitors in advanced breast cancer.
Authors: Ferrando, L.1 (AUTHOR), Dameri, M.2 (AUTHOR), Becherini, P.3 (AUTHOR), Galardi, F.4 (AUTHOR), Paoli, M.5 (AUTHOR), Moretti, E.5 (AUTHOR), Biagioni, C.5 (AUTHOR), Romagnoli, D.6 (AUTHOR), Romagnoli, S.7 (AUTHOR), Ravera, F.8 (AUTHOR), Ballestrero, A.9 (AUTHOR), Malorni, L.4 (AUTHOR), Benelli, M.6 (AUTHOR), Zoppoli, G.10 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS404-S405. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.915